Arcline Investment Management Acquires Polypeptide Therapeutic Solutions (PTS)

April 27, 2021

Arcline Investment Management, a growth-oriented private equity firm, has acquired Polypeptide Therapeutic Solutions, S.L. (PTS) from Columbus Venture Partners. PTS is a Valencia-based GMP CDMO specializing in polyamino-acid (PAA) nanoparticle encapsulation and related drug-delivery services; Arcline plans to scale GMP production and expand the company's technology portfolio to support mRNA, gene/cell therapies, biologics and vaccines.

Targets
Polypeptide Therapeutic Solutions, S.L. (PTS)
Sellers
Columbus Venture Partners
Industry
Biotechnology
Location
Valencian Community, Spain
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.